BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32046847)

  • 1. (Strept)avidin as a template for ligands other than biotin: An overview.
    Hytönen VP
    Methods Enzymol; 2020; 633():21-28. PubMed ID: 32046847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features of steroid-binding antidins and their use for assaying serum progesterone.
    Agrawal N; Lehtonen SI; Uusi-Mäkelä M; Jain P; Viitala S; Määttä JAE; Kähkönen N; Azizi L; Riihimäki TA; Kulomaa MS; Johnson MS; Hytönen VP; Airenne TT
    PLoS One; 2019; 14(2):e0212339. PubMed ID: 30785944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Avidin-Based Receptors for a Panel of Small Molecules.
    Lehtonen SI; Tullila A; Agrawal N; Kukkurainen S; Kähkönen N; Koskinen M; Nevanen TK; Johnson MS; Airenne TT; Kulomaa MS; Riihimäki TA; Hytönen VP
    ACS Chem Biol; 2016 Jan; 11(1):211-21. PubMed ID: 26550684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered avidins and streptavidins.
    Laitinen OH; Hytönen VP; Nordlund HR; Kulomaa MS
    Cell Mol Life Sci; 2006 Dec; 63(24):2992-3017. PubMed ID: 17086379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The X-ray three-dimensional structure of avidin.
    Rosano C; Arosio P; Bolognesi M
    Biomol Eng; 1999 Dec; 16(1-4):5-12. PubMed ID: 10796979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the loops in the ligand-binding site turns avidin into a steroid-binding protein.
    Riihimäki TA; Hiltunen S; Rangl M; Nordlund HR; Määttä JA; Ebner A; Hinterdorfer P; Kulomaa MS; Takkinen K; Hytönen VP
    BMC Biotechnol; 2011 Jun; 11():64. PubMed ID: 21658230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimer-tetramer transition between solution and crystalline states of streptavidin and avidin mutants.
    Pazy Y; Eisenberg-Domovich Y; Laitinen OH; Kulomaa MS; Bayer EA; Wilchek M; Livnah O
    J Bacteriol; 2003 Jul; 185(14):4050-6. PubMed ID: 12837778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions to the binding free energy of ligands to avidin and streptavidin.
    Lazaridis T; Masunov A; Gandolfo F
    Proteins; 2002 May; 47(2):194-208. PubMed ID: 11933066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild conditions for releasing mono and bis-biotinylated macromolecules from immobilized streptavidin.
    Nguyen GH; Milea JS; Rai A; Smith CL
    Biomol Eng; 2005 Oct; 22(4):147-50. PubMed ID: 15886055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and multiple bonds in (strept)avidin-biotin interactions.
    Teulon JM; Delcuze Y; Odorico M; Chen SW; Parot P; Pellequer JL
    J Mol Recognit; 2011; 24(3):490-502. PubMed ID: 21504028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of novel tamavidin 2 muteins with lowered isoelectric points and lowered non-specific binding properties.
    Takakura Y; Oka N; Kajiwara H; Tsunashima M
    J Biosci Bioeng; 2012 Nov; 114(5):485-9. PubMed ID: 22795659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant avidin and avidin-fusion proteins.
    Airenne KJ; Marjomäki VS; Kulomaa MS
    Biomol Eng; 1999 Dec; 16(1-4):87-92. PubMed ID: 10796989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand exchange between proteins. Exchange of biotin and biotin derivatives between avidin and streptavidin.
    Pazy Y; Kulik T; Bayer EA; Wilchek M; Livnah O
    J Biol Chem; 2002 Aug; 277(34):30892-900. PubMed ID: 12055191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational development of caged-biotin protein-labeling agents and some applications in live cells.
    Terai T; Maki E; Sugiyama S; Takahashi Y; Matsumura H; Mori Y; Nagano T
    Chem Biol; 2011 Oct; 18(10):1261-72. PubMed ID: 22035795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin.
    Laitinen OH; Hytönen VP; Ahlroth MK; Pentikäinen OT; Gallagher C; Nordlund HR; Ovod V; Marttila AT; Porkka E; Heino S; Johnson MS; Airenne KJ; Kulomaa MS
    Biochem J; 2002 May; 363(Pt 3):609-17. PubMed ID: 11964162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifunctional avidin with covalently modifiable ligand binding site.
    Leppiniemi J; Määttä JA; Hammaren H; Soikkeli M; Laitaoja M; Jänis J; Kulomaa MS; Hytönen VP
    PLoS One; 2011 Jan; 6(1):e16576. PubMed ID: 21305032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
    Meyer SC; Gaj T; Ghosh I
    Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iminobiotin binding induces large fluorescent enhancements in avidin and streptavidin fluorescent conjugates and exhibits diverging pH-dependent binding affinities.
    Raphael MP; Rappole CA; Kurihara LK; Christodoulides JA; Qadri SN; Byers JM
    J Fluoresc; 2011 Mar; 21(2):647-52. PubMed ID: 21046439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the important Tyr-33 residue of chicken avidin: functional and structural consequences.
    Marttila AT; Hytönen VP; Laitinen OH; Bayer EA; Wilchek M; Kulomaa MS
    Biochem J; 2003 Jan; 369(Pt 2):249-54. PubMed ID: 12358604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essentials of biorecognition: the (strept)avidin-biotin system as a model for protein-protein and protein-ligand interaction.
    Wilchek M; Bayer EA; Livnah O
    Immunol Lett; 2006 Feb; 103(1):27-32. PubMed ID: 16325268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.